REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
22/06/2026
Voltar para busca
Dado oficial do USPTO
SMRT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
41
Atualização mais recente
23/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42, 44
Data de depósito
31/01/2019
Data de registro
22/06/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
22/06/2021
Última transação
23/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
AU
Examinador
ADEMI, XHENETA
Unidade examinadora
L70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Orthocell Limited
Representantes
Matthew J. Stark Price Heneveld LLP
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Stem cells for medical purposes for regeneration of bone and soft tissue; medical preparations for use in connection with the regeneration of bone and soft tissue; guided tissue regeneration materialsmedical preparations for use in connection with the regeneration of bone and soft tissue; biological preparations for medical purposesfor the regeneration of bone and soft tissue; tissue-regenerative medical preparationsfor use in connection with the regeneration of bone and soft tissue; medical preparations in the nature of tissues for medical usefor use in connection with the regeneration of bone and soft tissue; materials for dental treatmentdental preparations for use in connection with the regeneration of dental tissue; materials for making dental restorationsdental preparations for use in connection with the regeneration of dental tissue; dental repair materialsdental preparations for use in connection with the regeneration of dental tissue; dental restorative materialsdental preparations for use in connection with the regeneration of dental tissue; surgical implantsliving tissues grown from stem cells for use in connection with the regeneration of bone and soft tissue; collagen for medical use; medical preparations in the nature of biodegradable implants for use in guided tissue regenerationfor use in connection with the regeneration of bone and soft tissue; medical preparations in the nature of implant materials for use in guided tissue regeneration in surgeryfor use in connection with the regeneration of bone and soft tissue; medical preparations in the nature of implantable materials for use in guided tissue regenerationfor use in connection with the regeneration of bone and soft tissue; medical preparations in the nature of implants for guided tissue regenerationfor use in connection with the regeneration of bone and soft tissue; therapeutic agents for medical purposesfor the regeneration of bone and soft tissue; therapeutic biological tissue cultures for medical purposesfor the regeneration of bone and soft tissue; none of the aforementioned goods being or in relation to genomicssequencing of genomestranscriptomes or epigenomesmedical diagnostic assays and reagents for use in genetic sequencing and biochemical analysis
Classe 42
Scientific and technological research services in the field of biomechanical and cellular therapeutic medical techniques and design servicesdesign of new tissue and bone regeneration products and techniques related to biomechanical and cellular therapeutic techniques
Classe 44
Advisory services relating to medical services; physical therapy; medical services; medical advisory services; medical care services; medical health assessment services; medical treatment services for the regeneration of bone and soft tissue; provision of medical information; provision of medical services for the regeneration of bone and soft tissue; physical therapy services; all of the foregoing related to regeneration of bone and soft tissues and biomechanical and cellular therapeutic techniques
Publicações
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/11/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/10/2021
FIMP
FINAL DISPOSITION PROCESSED
08/10/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
22/09/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
22/06/2021
GPNX
NOTIFICATION PROCESSED BY IB
12/04/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/04/2021
PUBO
PUBLISHED FOR OPPOSITION
06/04/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
17/03/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
17/03/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/03/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/03/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
04/03/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/03/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
04/03/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/03/2021
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
25/09/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/09/2020
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
26/08/2020
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
24/07/2020
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
15/07/2020
ALIE
ASSIGNED TO LIE
29/06/2020
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
18/02/2020
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
07/02/2020
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
31/01/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/12/2019
GNSL
LETTER OF SUSPENSION E-MAILED
04/12/2019
CNSL
SUSPENSION LETTER WRITTEN
04/12/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/11/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/11/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/11/2019
RFNT
REFUSAL PROCESSED BY IB
25/05/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/05/2019
RFRR
REFUSAL PROCESSED BY MPU
03/05/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
18/04/2019
CNRT
NON-FINAL ACTION WRITTEN
17/04/2019
DOCK
ASSIGNED TO EXAMINER
10/04/2019
MAFR
APPLICATION FILING RECEIPT MAILED
30/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
26/03/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
21/03/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SMRT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.